James V. Caruso - Jul 2, 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Executive Officer, Director
Signature
/s/ Christina Blakley, attorney-in-fact for James V. Caruso
Stock symbol
CLRB
Transactions as of
Jul 2, 2025
Transactions value $
$50,000
Form type
4
Date filed
7/3/2025, 08:02 AM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CARUSO JAMES V Chief Executive Officer, Director C/O CELLECTAR BIOSCIENCES, INC., 100 CAMPUS DRIVE, FLORHAM PARK /s/ Christina Blakley, attorney-in-fact for James V. Caruso 2025-07-03 0001202770

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLRB Common Stock Purchase $49.9K +10K +610.5% $4.99 11.6K Jul 2, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Warrants Purchase $100 +10K $0.01 10K Jul 2, 2025 Common Stock 10K $5.25 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025.